十一月 2025
- Home
- Xenon Pharmaceuticals
十一月 2025的Xenon Pharmaceuticals市场份额分析
xenon pharmaceuticals is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders.
Xenon Pharmaceuticals(包含公司地区分支机构)
查看更多网站流量和参与度信息- xenon-pharma.com
Xenon Pharmaceuticals收入截至 十一月 2025为 15M - 25M
Xenon Pharmaceuticals主要域名产生的收入
3 年中Xenon Pharmaceuticals主要域名的收入
Xenon Pharmaceuticals主要域名的收入
十一月 2025的Xenon Pharmaceuticals股票价格
Xenon Pharmaceuticals的股票交易代码为 XENE。您可以在下面查看过去 12 个月的Xenon Pharmaceuticals股票表现(最多 十一月 2025)
Xenon Pharmaceuticals热门域名的总访问量
了解Xenon Pharmaceuticals市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Xenon Pharmaceuticals热门域名的平均访问时长
分析Xenon Pharmaceuticals参与度指标。
过去 3 个月的平均访问时长
子公司明细
Xenon Pharmaceuticals热门域名的平均页面浏览量
了解Xenon Pharmaceuticals如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Xenon Pharmaceuticals 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Xenon Pharmaceuticals Inc. attends event AES 2025.Xenon to present new azetukalner OLE study data in Epilepsy at AES 2025.
十一月 25, 2025阅读更多
新闻Xenon Pharmaceuticals Inc. hired Tucker Kelly as Chief Financial Officer on Oct 16th '25.VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced the appointment of Tucker Kelly as Chief Financial Officer (CFO) and member of the Xenon senior executive team.
十月 16, 2025阅读更多
新闻Xenon Pharmaceuticals Inc. is developing seizure medication.Abrahams, though, covers Xenon Pharmaceuticals, which is developing its own seizure medication that could rival Praxis'.
八月 4, 2025阅读更多
查看 Xenon Pharmaceuticals 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。